TMEM16A, a Homoharringtonine Receptor, as a Potential Endogenic Target for Lung Cancer Treatment

Lung cancer has the highest rate of incidence and mortality among all cancers. Most chemotherapeutic drugs used to treat lung cancer cause serious side effects and are susceptible to drug resistance. Therefore, exploring novel therapeutic targets for lung cancer is important. In this study, we evalu...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Shuai, Bai, Xue, Shi, Sai, Deng, Yawen, Kang, Xianjiang, An, Hailong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8535866/
https://www.ncbi.nlm.nih.gov/pubmed/34681590
http://dx.doi.org/10.3390/ijms222010930

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8535866/
https://www.ncbi.nlm.nih.gov/pubmed/34681590
http://dx.doi.org/10.3390/ijms222010930

Ejemplares similares